Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.94T | 4.70T | 3.77T | 2.74T | 2.83T | 3.34T | Gross Profit |
516.87B | 992.43B | 703.00B | 473.49B | 465.14B | 615.32B | EBIT |
103.30B | 482.05B | 280.06B | 97.20B | 108.57B | 214.82B | EBITDA |
324.99B | 693.58B | 511.04B | 318.05B | 310.41B | 406.13B | Net Income Common Stockholders |
78.70B | 385.08B | 200.43B | 70.01B | 76.51B | 152.59B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
886.82B | 1.05T | 1.37T | 1.13T | 1.14T | 858.97B | Total Assets |
2.87T | 4.81T | 3.94T | 3.54T | 3.41T | 3.29T | Total Debt |
52.03B | 399.50B | 427.12B | 441.17B | 435.53B | 321.66B | Net Debt |
-714.29B | -648.50B | -546.26B | -441.91B | -471.80B | -537.31B | Total Liabilities |
1.29T | 2.25T | 1.83T | 1.64T | 1.63T | 1.57T | Stockholders Equity |
1.57T | 2.56T | 2.10T | 1.89T | 1.78T | 1.71T |
Cash Flow | Free Cash Flow | ||||
129.45B | 467.79B | 308.89B | 9.41B | 96.85B | -3.94B | Operating Cash Flow |
307.88B | 767.66B | 503.76B | 195.65B | 289.38B | 210.13B | Investing Cash Flow |
-182.53B | -703.70B | -336.81B | -179.72B | -272.17B | -25.84B | Financing Cash Flow |
-99.47B | -66.47B | -122.31B | -98.50B | 13.97B | -15.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $13.60B | 5.45 | 15.47% | 2.08% | -1.05% | 12.63% | |
73 Outperform | $245.37B | 7.50 | 14.59% | 2.64% | -0.59% | 7.56% | |
73 Outperform | $46.56B | 6.87 | 8.11% | 2.56% | 4.37% | 6.93% | |
72 Outperform | $40.82B | 7.04 | 13.42% | 7.28% | 5.00% | 35.92% | |
72 Outperform | $52.33B | 8.26 | 9.44% | 0.94% | 9.08% | -15.25% | |
66 Neutral | $926.81B | 133.47 | 10.52% | ― | 0.95% | -52.81% | |
59 Neutral | $12.29B | 11.58 | 0.14% | 3.71% | 1.32% | -21.01% |